Important Animas Announcement | AMSL Diabetes
Connect

Customer Care 1300 851 056(Australia) +61 2 9882 3105(Overseas)

Johnson and Johnson (JNJ) have announced their intention to exit the insulin pump market globally. This follows an announcement in October last year that it was withdrawing from the US and Canadian markets. JNJ’s decision to close down its operations has been made for commercial reasons. AMSL Diabetes will continue to provide the same high level of support our customers currently receive and customers will still receive a replacement if their pump develops a fault while under warranty. Warranty and replacement pumps, as well as consumables, will not be affected by this announcement. Animas has also announced that in select countries it is working with a partner to transfer customers to another pump brand. Each market is being approached differently and in Australia, AMSL Diabetes will continue to work with Animas directly.

AMSL Diabetes have been proud partners of Animas for 15 years since launching the IR1000. We will continue to offer our leading 24/7 Australian-based customer service, technical support, and offer our full range of Dexcom CGM, Lifescan blood glucose meters, HypoPak fast acting glucose and accessory products.

UPDATE: It has been brought to our attention there has been miscommunication regarding the Animas announcement.

This misinformation in the market-place suggests that other parties are to provide support to Animas customers to facilitate continuation of insulin pump therapy.

We would like to reiterate this message is incorrect and reinforce AMSL Diabetes’ position in the market:

  • In some countries Animas is working with Medtronic as their preferred partner however this arrangement does not apply to Australia or NZ, where we have chosen a different solution which we feel is better for our customers to ensure that customers have a choice.

Customers will continue to deal with AMSL Diabetes for any matters relating to their Animas Vibe and other AMSL Diabetes products. We will continue to support all our customers.

  • Patients can continue to use their Animas Vibe as normal.
  • Replacement pumps will still be provided for any Animas Vibe that fails under warranty. Normal warranty conditions apply.
  • Consumables are not affected by the recent announcement.

AMSL Diabetes has been operating in the area of Diabetes for more than 15 years and is not exiting the insulin pump market.

For more information on how this announcement may affect you please contact AMSL Diabetes on 1300 851 056 or email diabetes@amsl.com.au.

We will have more updates and information on these latest developments soon. Make sure you follow us on our social media platforms (Facebook,Twitter or Instagram @amsldiabetes) to stay updated.

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.